CBL and neoplasm: Subsequent studies have revealed that homozygous Cbl mutations are present in most acquired uni-parental disomy myeloid malignancies, and that gain-of-function of mutations in Cbl are not associated with loss of the ubiquitin ligase activity, which is currently thought to play a tumor suppressing role30, 31.